1. Home
  2. Investing
  3. Stocks
  4. USA
  6. Outlook Therapeutics Inc (OTLK)
  7. Quote


Outlook Therapeutics Stock Price

0.01 (0.72%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 2,661,674
Bid Price 1.37
Ask Price 1.39
News -
Day High 1.43


52 Week Range


Day Low 1.31
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Outlook Therapeutics Inc OTLK NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.01 0.72% 1.39 20:00:01
Open Price Low Price High Price Close Price Prev Close
1.42 1.31 1.43 1.33 1.38
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
8,345 2,661,674 $ 1.36 $ 3,628,002 - 0.9285 - 4.26
Last Trade Time Type Quantity Stock Price Currency
18:55:31 formt 100 $ 1.39 USD


Draw Mode:

Outlook Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 311.50M 224.10M 152.06M $ - $ - -0.99 -5.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 219.17k 6.00%

more financials information »

Outlook Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical OTLK Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.251.541.241.412,757,3860.1411.2%
1 Month2.,403,088-0.74-34.74%
3 Months2.542.5951.191.791,275,119-1.15-45.28%
6 Months2.653.271.192.252,184,400-1.26-47.55%
1 Year1.174.260.92852.202,478,9060.2218.8%
3 Years5.6020.000.40111.971,884,817-4.21-75.18%
5 Years5.6020.000.40111.971,884,817-4.21-75.18%

Outlook Therapeutics Description

Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.

Your Recent History
Outlook Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.